Evidence map›Paper›PMID 41280767›Full record

ArticleACS omega2025

PPAC: Predicting Protein-Protein Affinity Changes Induced by Amino Acid Mutations Using Protein Large Language Models.

Leilei Zhang, Xiaofei Zhou, Lu Liang, Jianping Lin

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leilei ZhangNankai University, College of Pharmacy, Jinnan District, No.38 Tongyan Rd Haihe Education Garden, Tianjin 300350, China.
Xiaofei ZhouTianjin BioAi-Global Technology Co. Ltd, Hebei District, No. 185 Xindalu, Wanghailou Street, Tianjin 300140, China.
Lu LiangTianjin BioAi-Global Technology Co. Ltd, Hebei District, No. 185 Xindalu, Wanghailou Street, Tianjin 300140, China.
Jianping LinNankai University, College of Pharmacy, Jinnan District, No.38 Tongyan Rd Haihe Education Garden, Tianjin 300350, China.ORCID https://orcid.org/0000-0001-6974-0072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the impact of amino acid mutations on protein-protein binding free energy is fundamental to drug design and functional biology. We propose a novel approach utilizing Protein Large Language Models (PLMs) to characterize both wild-type and mutant proteins, enabling accurate predictions of mutational effects. We employed three state-of-the-art PLMsEsm2, EsmC, and ProtT5to generate sequence-based representations. These representations were subsequently integrated into seven distinct model architectures. Through a rigorous 5-fold cross-validation, we selected the optimal model and feature combination before training on a large-scale data set. Our results show that this PLM-based method significantly outperforms traditional approaches, achieving state-of-the-art (SOTA) predictive performance. The final PPAC model was evaluated on a test set of 9,558 data points and applied to two case studies. The results demonstrate that the model not only provides high-precision predictions but also exhibits a significant advantage in identifying key residues crucial for protein interactions, highlighting its effectiveness in protein interaction modeling.

Identifiers

PMID41280767
PMCPMC12631657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.